يعرض 1 - 20 نتائج من 42 نتيجة بحث عن '"Trastornos relacionados con opioides"', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المصدر: Spanish Journal of Human Nutrition and Dietetics; Vol. 25 No. 2 (2021): Spanish Journal of Human Nutrition and Dietetics; 227-236 ; Revista Española de Nutrición Humana y Dietética; Vol. 25 Núm. 2 (2021): Revista Española de Nutrición Humana y Dietética; 227-236 ; 2174-5145 ; 2173-1292

    وصف الملف: application/pdf

  3. 3
    Academic Journal
  4. 4
    Report
  5. 5
    Report

    المساهمون: Carlos Gil, AM, Castro Campos, JL Evaluación de Tecnologías Sanitarias de Andalucía, AETSA.

    وصف الملف: application/pdf

    Relation: https://www.aetsa.org/publicacion/diacetilmorfina-inyectable-como-tratamiento-de-trastornos-por-el-consumo-de-opiaceos/; Carlos Gil AM, Castro Campos JL. Diacetilmorfina Inyectable (heroína) como tratamiento de trastornos por el consumo de opiaceos: respuesta rápida. Sevilla: AETSA Evaluación de Tecnologías Sanitarias de Andalucía, Consejería de Salud y Familias; 2020.; http://hdl.handle.net/10668/3240

  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Dissertation/ Thesis
  13. 13

    المصدر: Revista de la Sociedad Española del Dolor v.28 n.2 2021
    SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
    instname
    SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
    Instituto de Salud Carlos III (ISCIII)

    وصف الملف: text/html

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16

    المساهمون: Daza Vergara, José Alejandro, Isaza Narváez, Ana Milena, Aguilera, Paula, Pedraza Flechas, Ana Maria

    المصدر: 1. Campbella, G., et al. The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015; Feb;156(2):231-42.
    2. Sehgal, N., Manchikanti, L., Smith, HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012 Jul;15(3 Suppl):ES67-92.
    3. Kaye, A.D. et al. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Pain Physician 2017; 20: S93-S109.
    4. Airam, A., Hammam A., Gururau S. Prevention of Opioid Abuse in Chronic Non-Cancer Pain: An Algorithmic, Evidence Based Approach. Pain Physician 2012; 15:ES177-ES189.
    5. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine. 2005;30:1075–1081.
    6. Voon P, Karamouzian M, Kerr T.Chronic pain and opioid misuse: a review of reviews. Substance Abuse Treatment, Prevention, and Policy 2017; 12:36.
    7. Palmer R.E, et al. The prevalence of problem opioid use in patients receiving chronic opioid therapy: computer-assisted review of electronic health record clinical notes. Pain 2015; Jul;156(7):1208-14.
    8. Boyd, C., et al. Motives for Medical Misuse of Prescription Opioids Among Adolescent. J Pain. 2013 Oct; 14(10): 1208–1216.
    9. Carter, J., et al. Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: Mathematical modeling using a database of commercially-insured individuals. Drug Alcohol Depend. 2014 May 1;138:202-8.
    11. Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012 Jun;72(6):443-51.
    12. Volkow, N., McLellan, A.T. Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies. Engl J Med 2016; 374:1253-1263.
    13. Guerrero A, Gómez P. VIII Estudio Nacional de Dolor 2014-Prevalencia del dolor crónico en Colombia. Asociación Colombiana para el Estudio de Dolor. 2016.
    14. Just J. et al. Risk of opioid misuse in chronic non-cancer pain in primary care patients-a cross sectional study. BMC Family Practice 2018; 19:92.
    15. Gobierno Nacional de la República de Colombia. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia. 2013.
    16. Pagé, M.G., et al. Risk of Opioid Abuse and Biopsychosocial Characteristics Associated With This Risk Among Chronic Pain Patients Attending a Multidisciplinary Pain Treatment Facility. Clin J Pain. 2016 Oct;32(10):859-69.
    17. Amsterdam J.V, Van den Brink W. The Misuse of Prescription Opioids: A Threat for Europe?. Current Drug Abuse Reviews 2015; 8: 3-14.
    18. Ballantyne, JC. Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions. Anesth Analg 2017;125:1769–78.
    19. Pergolizzi Jr, J. V., Gharibo, C., Passik, S., Labhsetwar, S., Taylor Jr, R., Pergolizzi, J. S., & Müller-Schwefe, G. Dynamic risk factors in the misuse of opioid analgesics. Journal of psychosomatic research 2012; 72(6): 443-451.
    20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub, 2013.
    21. American College of Preventive Medicine. Use, Abuse, Misuse, and disposal of prescription pain medication time tool: A Resource from the American College of Preventive Medicine. 2011. Tomado de: http://www.acpm.org/?UseAbuseRxClinRef
    22. Ballantyne, J.C, LaForge, K,S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129: 235–255.
    23. Johnson S, North R. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci. 1992; 12: 483–8.
    24. Bonci A, Williams J. Increased probability of GABA release during withdrawal from morphine. J Neurosci. 1997; 17: 796–803.
    25. Cami, J., Farre, M. Drug addiction. N Engl J Med 2003; 349: 975–86.
    26. Hyman S, Malenka R. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci. 2001; 2: 695–703.
    27. Robinson T, Berridge K. Addiction. Annu Rev Psychol 2003; 54: 25–53.
    28. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop. Ann Intern Med. 2015;162:276–86.
    29. Vowles K.E, McEntee M.L, Julnes P.S, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569-76.
    30. Webster, L. R. Risk factors for opioid-use disorder and overdose. Anesthesia & Analgesia 2017; 125(5): 1741-1748.
    31. McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. The Journal of Pain 2013:14: 1208-1216
    32. Kirson, N. Y., Scarpati, L. M., Enloe, C. J., Dincer, A. P., Birnbaum, H. G., & Mayne, T. J. The economic burden of opioid abuse: updated findings. Journal of managed care & specialty pharmacy 2017; 23(4): 427-445.
    33. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017 Mar 6 [Epub ahead of print].
    34. Klimas J, et al. Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain. JAMA Network Open 2019; 2(5): e193365.
    35. Grau, LE. Chronic pain, Addiction severity, and misuse of opioids in Cumberland County. Addict Behav. 2012 Mar;37(3):346-9.
    36. Pletcher M.J, Kertesz S.G, Kohn M.A, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. Jama. 2008; 299: 70-78.
    37. Lanier W.A., Johnson E.M., Rolfs R.T., Friedrichs M.D., Grey T.C. Risk Factors for Prescription Opioid-Related Death, Utah, 2008–2009. Pain Medicine 2012;13: 1580-1589.
    38. Akbik H, et al. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006; 32(3):287-293.
    39. Organización Mundial de la Salud . La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST)-Manual para uso en la atención primaria, 2011.
    40. Kanouse, A. B., & Compton, P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. Journal of pain & palliative care pharmacotherapy 2015; 29(2): 102-114.
    41. Lee, Y. H., Brown, D. L., & Chen, H. Y. Current Impact and Application of Abuse-Deterrent Opioid Formulations in Clinical Practice 2017; 20(7):E1003-E1023.
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  17. 17

    المساهمون: Pardo, Rosalba, Cárdenas Müller, Adriana, De la Hoz, Jose Antonio

    المصدر: 1. Orive P, López Fernández, Morteruel Arizkuren E. Protocolo de Síndrome de Abstinencia. Soc y Fund Española Cuid intensivos pediátricos. 2013.
    2. Moon YE. Paradoxical reaction to midazolam in children. Korean J Anesthesiol.2013;65(1):2–3
    3. Ista E, Van Dijk M, Gamel C, Tibboel D, De Hoog M. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics. Intensive Care Med.2007;33(8):1396–406.
    4. Valdivielso-Serna A. Analgesia, sedación y relajación en el niño con ventilación mecánica. Med Intensiva. 2008;32 Supl 1:115-24 115
    5. Galinkin J, Koh JL. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children. Pediatrics. 2014;133(1):152–5.
    6. Best KM, Boullata JI, Curley MAQ. Risk Factors Associated With Iatrogenic Opioid and Benzodiazepine Withdrawal in Critically Ill Pediatric Patients. Pediatr Crit Care Med. 2015;16(2):175–83.
    7. Jenkins I, Playfor SD, Bevan C, Davies G, Wolf AR. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth. 2007;17:675–83.
    8. Sfoggia A, Scolari P MA. Sedation and analgesia in children submitted to mechanical ventilation could be overestimated? J Pediatr (Rio J) 2003;79(4)343-8.
    9. Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Critical care medicine. 1999. p. 196–9.
    11. Pediátricos U de CI. Estadísticas Clínica Infantil Colsubsidio. Bogotá Colombia; 2015.
    12. Estadísticas Hospital del Niño de Panamá. Panamá; 2015
    13. Perrot L, Barrios K. Frecuencia del síndrome de abstinencia en la unidad de terapia intensiva del hospital del niño doctor josé renán esquivel. Marzo-mayo 2015. Archivos biblioteca Hospital del niño de Panamá. 2015
    14. Richman PS, Baram D, Varela M, Glass PS. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med. 2006;34(5):1395–401
    15. Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541–8.
    16. Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med. 2006;32(8):1125–36
    17. Twite MD, Rashid A, Zuk J, Friesen RH. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med. 2004;5(6):521–32.
    18. Nolent P, Laudenbach V. Sédation et analgésie en réanimation – Aspects pédiatriques. Ann Fr Anesth Reanim. 2008;27(7–8):623–32.
    19. Mencía SB, López-Herce JC, Freddi N. Analgesia and sedation in children: practical approach for the most frequent situations. J Pediatr (Rio J). 2007;83:S71–82.
    20. Fernández-Carrión F, Gaboli M, González-Celador R, Gómez de Quero-Masía P, Fernández-de Miguel S, Murga-Herrera V, et al. Síndrome de abstinencia en Cuidados Intensivos Pediátricos. Incidencia y factores de riesgo. Med Intensiva. 2012;37(2):67-74
    21. Volkow ND, McLellan TA. Characteristics of Opioid Prescriptions in 2009. JAMA J Am Med Assoc. 2011;305(13):1299–301.
    22. Rhoney DH, Murry KR. National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatr Crit Care Med. 2002;3(2):129–33.
    23. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med. 2012;185(5):486–97.
    24. Devlin J, Roberts RJ. Pharmacology of Commonly Used Analgesics and Sedatives in the ICU : Benzodiazepines, Propofol, and Opioids. Anesthesiology Clin 29(2011):567–585
    25. Mencía S. Monitorización de analgesia, sedación y bnm en ucip. Protocolo del grupo de sedoanalgesia de la secip. Secip. 2013;1–10.
    26. Bai J, Hsu L, Tang Y, Van Dijk M. Validation of the COMFORT Behavior Scale and the FLACC Scale for Pain Assessment in Chinese Children after Cardiac Surgery. Pain Manag Nurs. American Society for Pain Management Nursing; 2012;13(1):18–26.
    27. Voepel-Lewis T, Zanotti J, Dammeyer JA, Merkel S. Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients. Am J Crit Care. 2010;19(1):55–61.
    28. Vet NJ, Ista E, De Wildt SN, Van Dijk M, Tibboel D, De Hoog M. Optimal sedation in pediatric intensive care patients: a systematic review. Intensive Care Med. 2013;39(9):1524–34.
    29. Sauder P, Andreoletti M, Cambonie G, Capellier G, Feissel M, Gall O, et al. Sédation-analgésie en réanimation (nouveau-né exclu). Ann Fr Anesth Reanim. 2008;27(7–8):541–51.
    30. Andersen RD, Bernklev T, Langius-Eklof A, Nakstad B, Jylli L. The COMFORT behavioural scale provides a useful assessment of sedation, pain and distress in toddlers undergoing minor elective surgery. Acta Paediatr. 2015;104(9):904–9.
    31. Dorfman TL, Sumamo Schellenberg E, Rempel GR, Scott SD, Hartling L. An evaluation of instruments for scoring physiological and behavioral cues of pain, non-pain related distress, and adequacy of analgesia and sedation in pediatric mechanically ventilated patients: A systematic review. Int J Nurs Stud. Elsevier Ltd; 2014;51(4):654–76.
    32. Bustos R, Fuentes C. Correlación entre análisis biespectral y escala COMFORT en la evaluación de sedación en la Unidad de Cuidados Intensivos Pediátricos. Rev Chil pediatría. 2007;78(6):592–8.
    33. Harris J, Ramelet AS, Van Dijk M, Pokorna P, Wielenga J, Tume L, et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med. Springer Berlin Heidelberg; 2016;42(6):972–86.
    34. Neunhoeffer F, Kumpf M, Renk H, Hanelt M, Berneck N, Bosk A, et al. Nurse-driven pediatric analgesia and sedation protocol reduces withdrawal symptoms in critically ill medical pediatric patients. 2015;25:786–94.
    35. Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care. 1998;7(5):364–9.
    36. Franck LS, Naughton I, Winter I. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004;20:344–51.
    37. Birchley G. Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature. Nurs Crit Care. 2009;14(1):26–37.
    38. Gardner D. NIH Public Access. Neonatal Abstinence Syndrome (NAS): Transitioning Methadone Treated Infants From An Inpatient to an Outpatient Setting. 2013;32(6):425–30.
    39. Finnegan LP, Connaughton JF, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addictive diseases. 1975:141–58.
    40. Cunliffe M, McArthur L, Dooley F. Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. Paediatric Anaesthesia. 2004. p. 293–8.
    41. Amigoni A, Vettore E, Brugnolaro V, Brugnaro L, Gaffo D, Masola M, et al. High doses of benzodiazepine predict analgesic and sedative drug withdrawal syndrome in paediatric intensive care patients. Acta Paediatr. 2014;103(12):e538–43.
    42. Franck LS, Scoppettuolo L, Wypij D, Curley M. Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. Pain. International Association for the Study of Pain; 2012;153(1):142–8.
    43. Ista E, Van Dijk M, Hoog M, Tibboel D, Duivenvoorden HJ. Construction of the Sophia Observation withdrawal Symptoms-scale (SOS) for critically ill children. Intensive Care Med. 2009;35(6):1075–81.
    44. Ista E, De Hoog M, Tibboel D, Duivenvoorden HJ, Van Dijk M. Psychometric evaluation of the Sophia Observation withdrawal symptoms scale in critically ill children. Pediatr Crit Care Med. 2013;14(8):761–9.
    45. Fernández F, Sara M. Sedoanalgesia En Ucip. SECIP 2013:1–20. Disponible en: www.secip.com/publicaciones.../92-protocolos-gt-sedoanelgesia-2...
    46. Bauer T, Ritz R, Haberthür C, Haefeli W, Hunkeler W, Sleight J, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. The lancet.July1995;356(8969):145–7.
    47. Johnson PN, Miller JL, Hagemann TM. Sedation and Analgesia in Critically Ill Children. AACN Adv Crit Care. 2012;23(4):415–34.
    48. Celis-Rodríguez E, Birchenall C, De la Cal M.A, Arellano GC, Jimenez EJ, García JOS, et al. Guía de práctica clínica basada en la evidencia para el manejo de la sedoanalgesia en el paciente adulto críticamente enfermo. Med Intensiva 2013 http//dx.doi.org/101016/j.medin201304001. 2013;(xx).
    49. Bicudo JN, Souza N De, Mângia CMF, Carvalho WB. Síndrome de abstinência associada à interrupção da infusão de fentanil e midazolam em pediatria. Rev Assoc Med Bras. 1999;45(1):15–8.
    50. Dominguez KD. Withdrawal from Lorazepam in Critically Ill Children. Annals of Pharmacotherapy. 2006. p. 1035–9.
    51. Poh YN, Poh PF, Buang SNH, Lee JH. Sedation Guidelines, Protocols, and Algorithms in PICUs. Pediatr Crit Care Med. 2014;15(9):885–92.
    52. Franck LS, Scoppettuolo LA, Curley MAQ. Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. NIH Public Access. 2013;153(1):142–8.
    53. Meyer MM, Berens RJ. Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatr Crit Care Med. 2001;2(4):329–33.
    54. Lewandowski CM,. Protocolo de Metadona. University of Minnesota Amplatz Children’s Hospital. Eff Br mindfulness Interv acute pain Exp An Exam Individ Differ. 2015;1:1689–99.
    55. Fisher D, Grap MJ, Younger JB, Ameringer S, Elswick RK. Opioid withdrawal signs and symptoms in children: Frequency and determinants. Hear Lung J Acute Crit Care. Elsevier Inc; 2013;42(6):407–13.
    56. Subramaniam R, Playfor SD. Sedation and analgesia in critically ill children. Pediatrics and Child Health. 2011:25(4): 177-181.
    57. Hernández-Delgadillo GP, Cruz SL. Mecanismos de tolerancia analgésica a los opioides. Salud Ment.2005;28(3):22–31
    Repositorio EdocUR-U. Rosario
    Universidad del Rosario
    instacron:Universidad del Rosario

    وصف الملف: application/pdf

  18. 18
  19. 19
    Academic Journal
  20. 20
    Academic Journal